Prostanoid inhibition of canine parietal cells
- PMID: 2428241
- DOI: 10.1016/s0002-9343(86)80003-1
Prostanoid inhibition of canine parietal cells
Abstract
Cellular mechanisms underlying the anti-secretory actions of the prostaglandin E2 analogue enprostil were studied using enzyme-dispersed, elutriator-enriched canine parietal cells and the accumulation of the weak base 14C-labeled aminopyrine as a functional index. Enprostil inhibited the accumulation of aminopyrine stimulated by histamine and the phosphodiesterase inhibitor isobutylmethyl, but not by carbachol, gastrin, or dibutyryl cyclic adenosine monophosphate. Inhibition by enprostil was dose-dependent (0.1 nM to 1 microM), with maximal inhibition ranging from 65 to 95 percent. Over the same concentration range, enprostil inhibited the histamine-stimulated generation of cyclic adenosine monophosphate. This selective inhibition of histamine activation of parietal cell function was comparable to that found for prostaglandin E2. Forskolin, a diterpene that directly activates the catalytic subunit of adenylate cyclase, was also markedly inhibited by nanomolar concentrations of prostaglandin E2 and enprostil. We conclude that at least a component of the secretory inhibition by enprostil reflects direct interference with histamine stimulation of parietal cell adenylate cyclase.
Similar articles
-
Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase.Gastroenterology. 1988 May;94(5 Pt 1):1121-9. doi: 10.1016/0016-5085(88)90002-9. Gastroenterology. 1988. PMID: 2832242
-
Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.J Clin Invest. 1980 May;65(5):1222-9. doi: 10.1172/JCI109777. J Clin Invest. 1980. PMID: 6154063 Free PMC article.
-
Intracellular coupling of prostaglandin inhibition of acid secretion in isolated rabbit gastric parietal cells.Biochem Pharmacol. 1990 Jun 15;39(12):1905-11. doi: 10.1016/0006-2952(90)90608-n. Biochem Pharmacol. 1990. PMID: 1693850
-
Beta-adrenergic and prostanoid inhibition of canine fundic mucosal mast cells.Am J Physiol. 1989 Apr;256(4 Pt 1):G727-32. doi: 10.1152/ajpgi.1989.256.4.G727. Am J Physiol. 1989. PMID: 2468293
-
Review: antisecretory drugs: cellular mechanisms of action.Aliment Pharmacol Ther. 1987 Apr;1(2):77-89. doi: 10.1111/j.1365-2036.1987.tb00609.x. Aliment Pharmacol Ther. 1987. PMID: 2979219 Review.
Cited by
-
Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.Dig Dis Sci. 1990 Nov;35(11):1352-7. doi: 10.1007/BF01536740. Dig Dis Sci. 1990. PMID: 2121423
-
Inhibition of gastric acid secretion by epidermal growth factor. Effects on cyclic AMP and on prostaglandin production in rat isolated parietal cells.Biochem J. 1988 Nov 1;255(3):789-94. doi: 10.1042/bj2550789. Biochem J. 1988. PMID: 2463831 Free PMC article.
-
Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.Drugs. 1987 Nov;34(5):539-59. doi: 10.2165/00003495-198734050-00003. Drugs. 1987. PMID: 3121276 Review.
-
Effects of PGE2, misoprostol, and enprostil on guinea pig enterocyte adenylate cyclase. Clinical implications.Dig Dis Sci. 1993 Feb;38(2):316-20. doi: 10.1007/BF01307550. Dig Dis Sci. 1993. PMID: 8425443
-
Human jejunal secretion induced by prostaglandin E1: a dose-response study.Br J Clin Pharmacol. 1991 Apr;31(4):433-7. doi: 10.1111/j.1365-2125.1991.tb05559.x. Br J Clin Pharmacol. 1991. PMID: 2049253 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources